Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HIEU MINH VO

Allopathic & Osteopathic Physicians Family Medicine

NPI
1285255109
CMS profile
11451112
Location
ANAHEIM, CA

General Payments · PY2023–2024

$538.47

  • Reported across 14 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$488.53

12 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $488.53 12

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $172.04 3
Gilead Sciences, Inc. $154.25 2
Amgen Inc. $55.53 2
Vanda Pharmaceuticals Inc. $29.70 1
DEXCOM, INC. $25.39 1
Acerta Pharma LLC $19.94 1
ITI, Inc. $17.55 1
Lundbeck LLC $14.13 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $49.94 2
PY2024 $488.53 12

Payment records · PY2024 (12)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $31.09 07/09/2024 Food and Beverage Undisputed 01/23/2026 1111734327 CMS
Amgen Inc. $24.44 08/20/2024 Food and Beverage Undisputed 01/23/2026 1111734329 CMS
AstraZeneca Pharmaceuticals LP $19.94 08/06/2024 Food and Beverage Undisputed 01/23/2026 1105699652 CMS
Dexcom, Inc. $25.39 11/07/2024 Food and Beverage Undisputed 01/23/2026 1153303783 CMS
Gilead Sciences, Inc. $121.83 07/10/2024 Food and Beverage Undisputed 01/23/2026 1133748568 CMS
Gilead Sciences, Inc. $32.42 12/13/2024 Food and Beverage Undisputed 01/23/2026 1133748570 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.55 12/09/2024 Food and Beverage Undisputed 01/23/2026 1143339614 CMS
Lilly USA, LLC $25.00 04/19/2024 Food and Beverage Undisputed 01/23/2026 1135020610 CMS
Lilly USA, LLC $22.16 08/16/2024 Food and Beverage Undisputed 01/23/2026 1135001634 CMS
Lilly USA, LLC $124.88 08/21/2024 Food and Beverage Undisputed 01/23/2026 1135020612 CMS
Lundbeck LLC $14.13 06/22/2024 Food and Beverage Undisputed 01/23/2026 1145978805 CMS
Vanda Pharmaceuticals Inc. $29.70 07/23/2024 Food and Beverage Undisputed 01/23/2026 1133925341 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.